Handelsbanken Fonder Ab Atri Cure, Inc. Transaction History
Handelsbanken Fonder Ab
- $26.2 Billion
- Q4 2024
A detailed history of Handelsbanken Fonder Ab transactions in Atri Cure, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 19,700 shares of ATRC stock, worth $814,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,700
Previous 17,700
11.3%
Holding current value
$814,201
Previous $496,000
21.37%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ATRC
# of Institutions
214Shares Held
49.8MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$193 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$191 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$164 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$117 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$115 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.92B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...